These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11772421)

  • 1. Statins and inflammatory markers.
    Case CC; Ballantyne CM
    Curr Atheroscler Rep; 2002 Jan; 4(1):42-7. PubMed ID: 11772421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of inflammation and their clinical significance.
    Ballantyne CM; Nambi V
    Atheroscler Suppl; 2005 May; 6(2):21-9. PubMed ID: 15823493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.
    Arnaud C; Veillard NR; Mach F
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics and anti-inflammatory effect of HMG-CoA reductase inhibitors].
    Rosendo AB; Dal-Pizzol F; Fiegenbaum M; Almeida Sd
    Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):520-5. PubMed ID: 17684611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Wieland H
    Herz; 2000 Mar; 25(2):117-25. PubMed ID: 10829251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory biomarkers and statins.
    Blanco-Colio LM; Tuñón J; Martín-Ventura JL; Egido J
    Drugs Today (Barc); 2005 Mar; 41(3):171-7. PubMed ID: 15883614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U; Libby P
    Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance.
    Biasucci LM; Biasillo G; Stefanelli A
    Clin Chem Lab Med; 2010 Dec; 48(12):1685-91. PubMed ID: 20868311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and biomarkers of inflammation.
    Devaraj S; Rogers J; Jialal I
    Curr Atheroscler Rep; 2007 Jan; 9(1):33-41. PubMed ID: 17169243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins: the new aspirin?
    Veillard NR; Mach F
    Cell Mol Life Sci; 2002 Nov; 59(11):1771-86. PubMed ID: 12530513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and immunomodulatory effects of statins.
    Blanco-Colio LM; Tuñón J; Martín-Ventura JL; Egido J
    Kidney Int; 2003 Jan; 63(1):12-23. PubMed ID: 12472764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of statins in inflammation and atherosclerosis.
    Yoshida M
    J Atheroscler Thromb; 2003; 10(3):140-4. PubMed ID: 14564082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
    Gmiński J; Wojakowski W
    Przegl Lek; 1997; 54(11):782-7. PubMed ID: 9501689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations of statins in heart failure: inflammatory biomarkers and hormones.
    Khan BV; Rajagopalan S
    Heart Fail Clin; 2008 Apr; 4(2):171-6. PubMed ID: 18433697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory and immunomodulatory properties of statins.
    Shovman O; Levy Y; Gilburd B; Shoenfeld Y
    Immunol Res; 2002; 25(3):271-85. PubMed ID: 12018465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and plaque stability.
    Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R
    J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.